Mauna Kea Technologies
Manufacturing · France · 51-200 Employees
View Company Info for Free
Overview
Headquarters
9 Rue D'enghien, Paris, Ile-de-France, 7...Phone Number
+33 148240345Website
www.maunakeatech.comRevenue
$8.9 MillionStock Symbol
ALMKTIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Mauna Kea Technologies
Mauna Kea Technologies is a global medical device company pioneering real-time cellular imaging with its Cellvizio® platform. Their technology enhances diagnostic precision and surgical decision-making across gastroenterology, oncology, and pulmonology.Explore more
Mauna Kea Technologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mauna Kea Technologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Mauna Kea Technologies is spiking on competitors!
Earning: See what the market has to say on Mauna Kea Technologies recently announced quarterly report
Funding: Get notified immidiatlly once Mauna Kea Technologies has new funding data
Click to see if Mauna Kea Technologies had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Mauna Kea Technologies launches new products
Mauna Kea Technologies, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Mauna Kea Technologies
Check if Mauna Kea Technologies has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Mauna Kea Technologies is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Mauna Kea Technologies is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Mauna Kea Technologies.
Mauna Kea Technologies financials insights
Gather financial insights about Mauna Kea Technologies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2008
Series B
$30M
2017
Debt
$7.5M
2019
Unspecified
$8.4M
2021
Share Placement
$14.7M
2025
Debt
$2.1M
Other Financing Round
$5.8M
Mauna Kea Technologies Tech Stack
A closer look at the technologies used by Mauna Kea Technologies
See more technologies
Most Recent Scoops
Earnings
Mauna Kea Technologies has reported revenue of €3.2 million for the first half of fiscal 2026, reflecting a 44% increase at constant exchange rates compared to the first half of 2025, or 39% growth on a reported basis.
Earnings, Finance
Product Launch
Mauna Kea Technologies has introduced a new miniaturized probe with a diameter of 0.45 mm, reduced from the previous 0.85 mm, enabling access to smaller pancreatic cysts using finer needles and potentially doubling the addressable market for this indication.
Product Development, Medical Research
Project
Mauna Kea Technologies has introduced real-time telemetry functionality to its Cellvizio systems in the United States, enabling direct 4G/5G network connectivity that allows the company to monitor the number of procedures performed in real time.
Healthcare Technology
Earnings
Mauna Kea Technologies has reported a 6.5% increase in average probe pricing over the past two years, alongside a steady reduction in average discounts, with the Acuflex probe for pancreatic cysts now carrying an average discount of approximately 10%.
Pricing
Earnings
Partnership, Financial Planning, Pharmaceuticals, Business Finance, Corporate Strategy, Finance, Financial Strategy
Mauna Kea Technologies News & Media
Mauna Kea Technologies Unveils CellTolerance, a Subsidiary Dedicated to its Unique Program for the Detection and Treatment of Food Intolerances
PARIS & BOSTON--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary platform for probe-based and needle-based confocal laser endomicroscopy (p/nCLE), unveils its new subsidiary CellTolerance1, fully dedicated to its unique program for the detection and treatment of food intolerances associated with Irritable Bowel Syndrome (IBS). “CellTolerance™ represents a significant advancement in the detection and treatment of fooMauna Kea Technologies Reports Full Year 2023 Results and Q1 2024 Sales
PARIS & BOSTON--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today reported its financial results for the full year 2023 and its sales for the first quarter 2024. For full year 2023, total Group sales increased by 42% to €10.5m, driven by the strong volume growth of the PPU business in the U.S. and the substantial contribution of licensing sMauna Kea Technologies Announces the Opening of the First Italian Center of Excellence for the Use of Cellvizio® to Identify and Treat Food Intolerance in Adults
PARIS & BOSTON--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT) (Paris:ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced the opening of the first Italian Center of Excellence for the use of Cellvizio to identify and treat food intolerances in adult patients suffering from Irritable Bowel Syndrome (IBS). The Cellvizio Food Intolerance Test (C-FIT) is now performed by Dr.Mauna Kea Technologies Appoints Benoit Chardon as Senior Advisor
PARIS & BOSTON–(BUSINESS WIRE)–Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio, the multidisciplinary probe and needle-based confocal laser endomicroscopy... Read More The post Mauna Kea Technologies Appoints Benoit Chardon as Senior Advisor appeared first on citybiz.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mauna Kea Technologies
Sign Up For FreeTo access detailed company insights
Mauna Kea Technologies is a global medical device company pioneering real-time cellular imaging with its Cellvizio® platform. Their technology enhances diagnostic precision and surgical decision-making across gastroenterology, oncology, and pulmonology.... Read More
